Fig. 6: Kaplan–Meier curves of event-free survival (EFS). | npj Breast Cancer

Fig. 6: Kaplan–Meier curves of event-free survival (EFS).

From: Image analysis-based tumor infiltrating lymphocytes measurement predicts breast cancer pathologic complete response in SWOG S0800 neoadjuvant chemotherapy trial

Fig. 6

EFS by a treatment with or without bevacizumab, b easTILs% high or low and treatment status, c sTILs% high or low and treatment status. easTILs% dichotomized at the value of 19.9%. sTILs% dichotomized at the value of 20%. TILs tumor-infiltrating lymphocytes, easTILs% [sum of lymphocytes area/stromal area] × 100, sTILs% pathologist assessment of stromal TILs, RD residual disease, pCR pathologic complete response, ctrl control group with chemotherapy, bev bevacizumab + chemotherapy group. Statistical analysis was performed using the log-rank test.

Back to article page